Research Scientist
Nithyadevi.Duraisamy@liu.edu
Education:
Ph.D. in Interdisciplinary Physics-Nanotechnology (Material Science), Bharathiar University – Coimbatore, India
PG Diploma : Nanoscience and Technology, Bharathiar University – Coimbatore, India
Master of Philosophy: Physics, Bharathiar University – Coimbatore, India
Master of Science: Physics, PSG College of Arts and Science – Coimbatore, India
Bachelor of Science: Physics, Vellalar College for Women – Erode, Coimbatore, India
Specialties:
Nano-Biomaterials, Regenerative Medicine, Targeted Therapy, AI-Driven In-silico Drug Discovery
Dr. Nithyadevi Duraisamy is an interdisciplinary scientist and educator with a strong academic foundation in nanotechnology, biomaterials, and physics. She currently serves as a Research Scientist in the Department of Excellence and AI at Long Island University, Brooklyn, New York. She joined LIU in 2023 as a Postdoctoral Research Fellow and was appointed to her current role in 2024. Dr. Duraisamy received her Ph.D. in Interdisciplinary Physics–Nanotechnology (Material Science) from Bharathiar University, India, in 2015. Her academic qualifications include an M.Phil. in Physics, a Postgraduate Diploma in Nanoscience and Technology, an M.Sc. in Physics, and a B.Sc. in Physics. Throughout her academic path, she has demonstrated consistent excellence in bridging physics, material science, and life sciences.
She previously held a research assistant position at the University of Connecticut Health Center from 2019 to 2021, contributing to interdisciplinary projects within the Department of Biomedical Engineering & Orthopedic Surgery. Before relocating to the U.S., she served as an Assistant Professor in the Department of Science and Humanities at Builders Engineering College, India (2015–2016), where she taught foundational physics. She has also served as an Adjunct Professor at LIU Post Campus (2024) and as a Graduate Teaching Assistant (2013 – 2015) during her doctoral tenure.
Dr. Duraisamy has been recognized for her contributions to academia with several honors, including the Best Faculty Award (2016) by Erode Builders Educational Trust and the prestigious UGC Fellowship for Meritorious Students (2013) during her doctoral studies. In addition to her academic roles, she is actively involved in the scientific publishing and peer review community. She serves as a peer reviewer for several international journals including Bioactive Materials, Journal of Biomaterials Applications, Heliyon, Applied Nanoscience, Journal of Membrane Science, and Journal of Biomimetics, Biomaterials and Biomedical Engineering.
Dr. Duraisamy has participated in and contributed to numerous conferences and symposia across interdisciplinary research areas, with particular emphasis on biomaterials, computational biology, and translational nanotechnology. Her scholarly works have been published in peer-reviewed journals, including a highly cited review article in Bioactive Materials.
Dr. Nithyadevi Duraisamy is an interdisciplinary research scientist with over seven years of experience integrating computational modeling and experimental approaches to address critical biomedical challenges. Her expertise spans nanotechnology, immunoinformatics, regenerative medicine, and disease modeling. She is currently a Research Scientist in the Department of Excellence and AI at Long Island University, Brooklyn, where she utilizes advanced facilities including an ISO 9-certified cleanroom and cell culture suite, equipped with 2D/3D systems, ELISA plate readers, live-cell imaging, HPLC, qPCR, and biosafety cabinets. Her research bridges in-silico analysis with experimental validation to deliver translational outcomes.
1. Multiepitope Vaccine Design for Veterinary Viruses:
Dr. Duraisamy leads the design of AI-driven, multiepitope-based vaccines targeting veterinary coronaviruses and influenza. Utilizing tools such as VaxiJen, IEDB, AlphaFold2, and C-ImmSim, she performs antigenicity prediction, immune simulation, and structural epitope mapping. Her approach enables the rational development of safe, highly immunogenic vaccines, with ongoing efforts to translate these in-silico findings into experimental validation and field application.
2. Early-Stage Knee Osteoarthritis: Diagnostics and Flavonoid Therapeutics:
Her research identifies and models key molecular targets—particularly ADAMTS4 and ADAMTS5—associated with early cartilage degradation under biomechanical stress. Using molecular docking and simulations, she evaluates flavonoids and small molecules as potential inhibitors of these enzymes. This work supports the development of diagnostic strategies and targeted therapeutics aimed at halting or reversing osteoarthritic progression at the molecular level.
3. Organ-on-Chip Platforms for Disease Modeling and Drug Screening:
Dr. Duraisamy develops and validates microfluidic organ-on-chip (OoC) systems to replicate liver, cardiac, and neural microenvironments. These systems enable real-time analysis of drug toxicity, fluid dynamics, and cellular responses in a physiologically relevant context. Her research integrates these platforms with computational models to enhance prediction of therapeutic outcomes and improve preclinical screening fidelity.
4. Cancer Research on Metastasis-Associated Protein 1 (MTA1):
In collaboration, Dr. Duraisamy investigates the molecular role of MTA1 in bone metastasis and prostate cancer. The project utilizes genetically engineered mouse models, molecular docking, and ADME-toxicity predictions to explore flavonoids and small molecules as inhibitors of MTA1-driven cancer progression. This research aims to identify novel therapeutic targets and develop natural compound-based anticancer agents with translational potential.
LIU is an EO/AA/ADA educator and employer and does not discriminate on the basis of race, color, national and ethnic origin, or religion, sex, sexual orientation, gender identity or expression, age, physical or mental disability, marital or veteran status in administration of its educational policies, admissions policies, scholarship and loan programs, and athletic and other school-administered programs. LIU admits students of any race, color, national, and ethnic origin to all the rights, privileges, programs and activities generally accorded or made available to its students.
Brooklyn Campus
1 University Plaza
Brooklyn, NY 11201
718-488-1011
Post Campus
720 Northern Blvd.
Brookville, NY 11548
516-299-2900
Choose Your Campus
Brooklyn
Post
Global
Pharmacy
Veterinary Medicine
Choose Your Campus
Brooklyn
Post
Global
Pharmacy
Veterinary Medicine
LIU is an EO/AA/ADA educator and employer and does not discriminate on the basis of race, color, national and ethnic origin, or religion, sex, sexual orientation, gender identity or expression, age, physical or mental disability, marital or veteran status in administration of its educational policies, admissions policies, scholarship and loan programs, and athletic and other school-administered programs. LIU admits students of any race, color, national, and ethnic origin to all the rights, privileges, programs and activities generally accorded or made available to its students.